Shares of Crescita Therapeutics Inc. (TSE:CTX – Get Free Report) traded down 2.3% during trading on Thursday . The stock traded as low as C$0.43 and last traded at C$0.43. 4,515 shares were traded during mid-day trading, a decline of 74% from the average session volume of 17,152 shares. The stock had previously closed at C$0.44.
Crescita Therapeutics Price Performance
The stock has a market capitalization of C$8.40 million, a PE ratio of -4.30 and a beta of 1.66. The company has a current ratio of 3.80, a quick ratio of 2.29 and a debt-to-equity ratio of 6.66. The company’s 50 day simple moving average is C$0.42 and its 200 day simple moving average is C$0.47.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Further Reading
- Five stocks we like better than Crescita Therapeutics
- What Are Trending Stocks? Trending Stocks Explained
- Hasbro’s Management Made All the Right Calls This Quarter
- Investing in large cap stocks: Diving into big caps
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Want to Profit on the Downtrend? Downtrends, Explained.
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
